Clinical Trial Update: Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury

View source ↗

Summary

This completed clinical trial evaluated cerebrospinal fluid hemoglobin as a biomarker to monitor aneurysmal subarachnoid hemorrhage–related secondary brain inju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Delayed Cerebral Ischemia
• Delayed Ischemic Neurological Deficit
• Vasospasm

Snippet

Sponsor: University of Zurich | Conditions: Subarachnoid Hemorrhage, Aneurysmal, Vasospasm | Status: COMPLETED